Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 6, 2019
[ Wed, Mar 06th 2019
] - WOPRAI
[ Wed, Mar 06th 2019
] - WOPRAI
[ Wed, Mar 06th 2019
] - WOPRAI
[ Wed, Mar 06th 2019
] - WOPRAI
[ Wed, Mar 06th 2019
] - WOPRAI
[ Wed, Mar 06th 2019
] - WOPRAI
Tue, March 5, 2019
[ Tue, Mar 05th 2019
] - WOPRAI
[ Tue, Mar 05th 2019
] - WOPRAI
[ Tue, Mar 05th 2019
] - WOPRAI
[ Tue, Mar 05th 2019
] - WOPRAI
[ Tue, Mar 05th 2019
] - WOPRAI
[ Tue, Mar 05th 2019
] - WOPRAI
[ Tue, Mar 05th 2019
] - WOPRAI
[ Tue, Mar 05th 2019
] - WOPRAI
[ Tue, Mar 05th 2019
] - WOPRAI
Mon, March 4, 2019
[ Mon, Mar 04th 2019
] - WOPRAI
[ Mon, Mar 04th 2019
] - WOPRAI
[ Mon, Mar 04th 2019
] - WOPRAI
[ Mon, Mar 04th 2019
] - WOPRAI
[ Mon, Mar 04th 2019
] - WOPRAI
Matthew Harrison Maintained (SRPT) at Buy with Increased Target to $169 on, Mar 4th, 2019
Matthew Harrison of Morgan Stanley, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $161 to $169 on, Mar 4th, 2019.
Matthew has made no other calls on SRPT in the last 4 months.
There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $201 on, Friday, March 1st, 2019
- Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $231 on, Thursday, February 28th, 2019
- Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $230 on, Thursday, February 28th, 2019
Similar Stocks and Investing Articles
[ Fri, Mar 01st 2019
] - WOPRAI
[ Tue, Nov 06th 2018
] - WOPRAI
[ Thu, Sep 06th 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Wed, Mar 14th 2018
] - WOPRAI
[ Tue, Mar 13th 2018
] - WOPRAI
[ Mon, Mar 12th 2018
] - WOPRAI
[ Tue, Mar 06th 2018
] - WOPRAI
[ Thu, Apr 24th 2014
] - WOPRAI